138 related articles for article (PubMed ID: 30257098)
21. Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways.
Wang FS; Lian WS; Lee MS; Weng WT; Huang YH; Chen YS; Sun YC; Wu SL; Chuang PC; Ko JY
J Mol Med (Berl); 2017 May; 95(5):499-512. PubMed ID: 28130569
[TBL] [Abstract][Full Text] [Related]
22. Relationship of sclerostin and secreted frizzled protein polymorphisms with bone mineral density: an association study with replication in postmenopausal women.
Valero C; Zarrabeitia MT; Hernández JL; Pineda B; Cano A; García-Pérez MA; Riancho JA
Menopause; 2011 Jul; 18(7):802-7. PubMed ID: 21441835
[TBL] [Abstract][Full Text] [Related]
23. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.
Melville KM; Kelly NH; Khan SA; Schimenti JC; Ross FP; Main RP; van der Meulen MC
J Bone Miner Res; 2014 Feb; 29(2):370-9. PubMed ID: 24038209
[TBL] [Abstract][Full Text] [Related]
24. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.
Ohyama Y; Nifuji A; Maeda Y; Amagasa T; Noda M
Endocrinology; 2004 Oct; 145(10):4685-92. PubMed ID: 15217980
[TBL] [Abstract][Full Text] [Related]
25. Anti-sclerostin antibodies: utility in treatment of osteoporosis.
Clarke BL
Maturitas; 2014 Jul; 78(3):199-204. PubMed ID: 24842796
[TBL] [Abstract][Full Text] [Related]
26. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.
Li F; Cain JD; Tombran-Tink J; Niyibizi C
J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618
[TBL] [Abstract][Full Text] [Related]
27. Association of the I264T variant in the sulfide quinone reductase-like (SQRDL) gene with osteoporosis in Korean postmenopausal women.
Jin HS; Kim J; Park S; Park E; Kim BY; Choi VN; Yoo YH; Kim BT; Jeong SY
PLoS One; 2015; 10(8):e0135285. PubMed ID: 26258864
[TBL] [Abstract][Full Text] [Related]
28. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
[TBL] [Abstract][Full Text] [Related]
29. Rat Osteosarcoma Cells as a Therapeutic Target Model for Osteoregeneration via Sclerostin Knockdown.
Sedaghati B; Jahroomishirazi R; Starke A; Hacker MC; Schulz-Siegmund M
Cells Tissues Organs; 2016; 201(5):366-79. PubMed ID: 27233518
[TBL] [Abstract][Full Text] [Related]
30. Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women.
Reppe S; Lien TG; Hsu YH; Gautvik VT; Olstad OK; Yu R; Bakke HG; Lyle R; Kringen MK; Glad IK; Gautvik KM
Epigenetics; 2017 Aug; 12(8):674-687. PubMed ID: 28650214
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide is involved in the down-regulation of SOST expression induced by mechanical loading.
Delgado-Calle J; Riancho JA; Klein-Nulend J
Calcif Tissue Int; 2014 Apr; 94(4):414-22. PubMed ID: 24322886
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional control of Sost in bone.
Sebastian A; Loots GG
Bone; 2017 Mar; 96():76-84. PubMed ID: 27771382
[TBL] [Abstract][Full Text] [Related]
33. Systems genetics and bioinformatics analyses using ESR1-correlated genes identify potential candidates underlying female bone development.
Bajpai AK; Gu Q; Jiao Y; Starlard-Davenport A; Gu W; Quarles LD; Xiao Z; Lu L
Genomics; 2024 Jan; 116(1):110769. PubMed ID: 38141931
[TBL] [Abstract][Full Text] [Related]
34. Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer.
Khalid O; Baniwal SK; Purcell DJ; Leclerc N; Gabet Y; Stallcup MR; Coetzee GA; Frenkel B
Endocrinology; 2008 Dec; 149(12):5984-95. PubMed ID: 18755791
[TBL] [Abstract][Full Text] [Related]
35. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW
Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
[TBL] [Abstract][Full Text] [Related]
36. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
Li X; Ominsky MS; Niu QT; Sun N; Daugherty B; D'Agostin D; Kurahara C; Gao Y; Cao J; Gong J; Asuncion F; Barrero M; Warmington K; Dwyer D; Stolina M; Morony S; Sarosi I; Kostenuik PJ; Lacey DL; Simonet WS; Ke HZ; Paszty C
J Bone Miner Res; 2008 Jun; 23(6):860-9. PubMed ID: 18269310
[TBL] [Abstract][Full Text] [Related]
37. Local origins impart conserved bone type-related differences in human osteoblast behaviour.
Shah M; Gburcik V; Reilly P; Sankey RA; Emery RJ; Clarkin CE; Pitsillides AA
Eur Cell Mater; 2015 Mar; 29():155-75; discussion 175-6. PubMed ID: 25738584
[TBL] [Abstract][Full Text] [Related]
38. Variations of SOST mRNA expression in human bone are associated with DNA polymorphism and DNA methylation in the SOST gene.
Lhaneche L; Hald JD; Domingues A; Hannouche D; Delepine M; Zelenika D; Boland A; Ostertag A; Cohen-Solal M; Langdahl BL; Harsløf T; de Vernejoul MC; Geoffroy V; Jehan F
Bone; 2016 Nov; 92():107-115. PubMed ID: 27519970
[TBL] [Abstract][Full Text] [Related]
39. Carbonate apatite increases gene expression of osterix and bone morphogenetic protein 2 in the alveolar ridge after socket grafting.
Kitazawa T; Takai H; Kono T; Okada H; Ogata Y
J Oral Sci; 2024 Jan; 66(1):15-19. PubMed ID: 38008425
[TBL] [Abstract][Full Text] [Related]
40. Mechanical strain-mediated reduction in RANKL expression is associated with RUNX2 and BRD2.
Galea GL; Paradise CR; Meakin LB; Camilleri ET; Taipaleenmaki H; Stein GS; Lanyon LE; Price JS; van Wijnen AJ; Dudakovic A
Gene X; 2020 Dec; 5():100027. PubMed ID: 32550554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
